Abstract: A weld coupon destructive test device includes a support base. A plunger connected to the support base and movable between a first position and a second position along a length of the support base. A handle to operate the plunger between the first position and the second position. A header on the support base, the header configured to press a weld coupon between the header and the plunger, the header having a first support end and a second support end, the header having a depression formed between the first support end and the second support end. The weld coupon rests between the first support end and the second support end of the header, and the weld coupon is pressed into the depression formed between the first support end and the second support end of the header.

Abstract: The invention relates to solid pharmaceutical dosage forms comprising an extended release core comprising metformin hydrochloride and one or two immediate release coatings comprising linagliptin and/or empagliflozin.

Abstract: A weld coupon destructive test device includes a support base. A plunger connected to the support base and movable between a first position and a second position along a length of the support base. A handle to operate the plunger between the first position and the second position. A header on the support base, the header configured to press a weld coupon between the header and the plunger, the header having a first support end and a second support end, the header having a depression formed between the first support end and the second support end. The weld coupon rests between the first support end and the second support end of the header, and the weld coupon is pressed into the depression formed between the first support end and the second support end of the header.

Abstract: A weld coupon destructive test device includes a support base. A plunger is connected to the support base and is movable along a length of the support base by a handle mounted to rotate on a pivot base on the support base. A header on the support base has a guide surface configured to press a weld coupon between the guide surface and the head of the plunger. A guide shoe is configured to fit against the guide surface of the header, the curved guide shoe has a first face and a second face, the first face is curved to conform to the head on the plunger, and the second face is curved to conform to the curved guide surface of the header. The handle is operable in a slotted bar to break a weld coupon under pressure.

Abstract: A weld coupon destructive test device includes a support base. A plunger is connected to the support base and is movable along a length of the support base by a handle mounted to rotate on a pivot base on the support base. A header on the support base has a guide surface configured to press a weld coupon between the guide surface and the head of the plunger. A guide shoe is configured to fit against the guide surface of the header, the curved guide shoe has a first face and a second face, the first face is curved to conform to the head on the plunger, and the second face is curved to conform to the curved guide surface of the header. The handle is operable in a slotted bar to break a weld coupon under pressure.

Abstract: The invention relates to solid pharmaceutical dosage forms comprising an extended release core comprising metformin hydrochloride and one or two immediate release coatings comprising linagliptin and/or empagliflozin.

Abstract: The present invention relates to pharmaceutical compositions comprising fixed dose combinations of a DPP-4 inhibitor drug and metformin XR (extended release), processes for the preparation thereof, and their use to treat certain diseases.